TMDX
insider transactionsTransMedics Group, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-17.4K
25.6K buy · 43.0K sell
Net value · 365d
-$2.4M
$3.0M in · $5.4M out
Sentiment · 365d
Net selling
36% buying · 64% selling
Open-market trades · 365d
17
25.6K buy · 43.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Exercise·M
Director
$0
19.3K sh
Own New
-
Sell·S
Director
$722.4K
9.6K sh · $75.06
Own -37%
-
Exercise·M
Director
$42.6K
19.3K sh · $2.21
Own +276%
-
Grant·A
Director
$0
2.9K sh
Own +24%
-
Grant·A
Director
$0
2.9K sh
Own +72%
-
Grant·A
Director
$0
2.9K sh
Own +72%
-
Grant·A
Director
$0
2.9K sh
Own +102%
-
Grant·A
Director
$0
2.9K sh
Own +1%
-
Grant·A
Director
$0
2.9K sh
Own +72%
-
Grant·A
Director · 10b5-1
$0
2.9K sh
Own +102%
-
Grant·A
Senior Vice President, Genera…
$0
23.2K sh
Own New
-
Grant·A
Senior Vice President, Genera…
$0
15.4K sh
Own New
-
Exercise·M
Chief Financial Officer
$0
7.2K sh · 2 lots
Own New
-
Sell·S
Chief Financial Officer
$1.1M
7.6K sh · $146.81 avg · 3 lots
Own -34%
-
Exercise·M
Chief Financial Officer
$515.0K
7.2K sh · $71.17 avg · 2 lots
Own +54%
-
Sell·S
Director
$178.5K
1.2K sh · $149.62
Own -29%
-
Exercise·M
Director
$0
3.6K sh
Own New
-
Exercise·M
Director
$50.7K
3.6K sh · $14.20
Own +29%
-
Sell·S
Director
$524.3K
3.6K sh · $146.82
Own -23%
-
Sell·S
See remarks
$120.2K
864 sh · $139.12
Own -6%
-
Sell·S
See remarks
$412.6K
3.0K sh · $139.12
Own -9%
-
Grant·A
Chief Commercial Officer
$0
16.7K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
11.1K sh
Own +139%
-
Other·F
See remarks
$133.1K
984 sh · $135.30
Own -3%
-
Sell·S
Chief Financial Officer
$128.5K
920 sh · $139.62
Own -6%
-
Exercise·M
Director
$0
5.0K sh
Own New
-
Sell·S
Director
$693.2K
5.0K sh · $138.64
Own -29%
-
Exercise·M
Director
$71.0K
5.0K sh · $14.20
Own +41%
-
Exercise·M
See remarks
$0
3.0K sh
Own +68%
-
Exercise·M
See remarks
$281.6K
3.0K sh · $93.88
Own +21%
-
Sell·S
See remarks
$435.7K
3.0K sh · $145.22
Own -18%
-
Buy·P
President & CEO
$1.0M
8.8K sh · $114.00
Own +2%
-
Exercise·M
Director · 10b5-1
—
4.1K sh
Own New
-
Sell·S
Director · 10b5-1
$540.3K
4.1K sh · $130.45
Own -59%
-
Exercise·M
Director · 10b5-1
$2.9K
4.1K sh · $0.70
Own +145%
-
Buy·P
President & CEO
$2.0M
16.9K sh · $117.46 avg · 3 lots
Own +4%
-
Exercise·M
Director · 10b5-1
—
4.1K sh
Own New
-
Sell·S
Director · 10b5-1
$520.0K
4.1K sh · $125.51
Own -59%
-
Exercise·M
Director · 10b5-1
$2.9K
4.1K sh · $0.70
Own +145%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Gunderson Thomas James | Exercise M | 19.3K | $0 |
| Jun 15, 2026 | Gunderson Thomas James | Sell S | 9.6K | $722.4K |
| Jun 15, 2026 | Gunderson Thomas James | Exercise M | 19.3K | $42.6K |
| May 20, 2026 | Weill David | Grant A | 2.9K | $0 |
| May 20, 2026 | TOBIN JAMES R | Grant A | 2.9K | $0 |
| May 20, 2026 | RAINES MERILEE | Grant A | 2.9K | $0 |
| May 20, 2026 | Lovell Stephanie | Grant A | 2.9K | $0 |
| May 20, 2026 | KANIA EDWIN M JR | Grant A | 2.9K | $0 |
| May 20, 2026 | Gunderson Thomas James | Grant A | 2.9K | $0 |
| May 20, 2026 | Basile Edward M 10b5-1 | Grant A | 2.9K | $0 |
| May 19, 2026 | Matthew S. Forsyth KEY | Grant A | 23.2K | $0 |
| May 19, 2026 | Matthew S. Forsyth KEY | Grant A | 15.4K | $0 |
| Mar 4, 2026 | Hernandez Gerardo KEY | Exercise M | 7.2K2 lots | $0 |
| Mar 4, 2026 | Hernandez Gerardo KEY | Sell S | 7.6K3 lots | $1.1M |
| Mar 4, 2026 | Hernandez Gerardo KEY | Exercise M | 7.2K2 lots | $515.0K |
| Mar 4, 2026 | Lovell Stephanie | Sell S | 1.2K | $178.5K |
| Mar 4, 2026 | Weill David | Exercise M | 3.6K | $0 |
| Mar 4, 2026 | Weill David | Exercise M | 3.6K | $50.7K |
| Mar 4, 2026 | Weill David | Sell S | 3.6K | $524.3K |
| Mar 2, 2026 | Ranganath Anil P. | Sell S | 864 | $120.2K |
| Mar 2, 2026 | Corcoran Nicholas | Sell S | 3.0K | $412.6K |
| Feb 18, 2026 | Cecere Giovanni | Grant A | 16.7K | $0 |
| Feb 18, 2026 | Cecere Giovanni | Grant A | 11.1K | $0 |
| Jan 23, 2026 | Corcoran Nicholas | Other F | 984 | $133.1K |
| Dec 4, 2025 | Hernandez Gerardo KEY | Sell S | 920 | $128.5K |
| Dec 3, 2025 | Weill David | Exercise M | 5.0K | $0 |
| Dec 3, 2025 | Weill David | Sell S | 5.0K | $693.2K |
| Dec 3, 2025 | Weill David | Exercise M | 5.0K | $71.0K |
| Nov 25, 2025 | Ranganath Anil P. | Exercise M | 3.0K | $0 |
| Nov 25, 2025 | Ranganath Anil P. | Exercise M | 3.0K | $281.6K |
| Nov 25, 2025 | Ranganath Anil P. | Sell S | 3.0K | $435.7K |
| Nov 17, 2025 | Hassanein Waleed H KEY | Buy P | 8.8K | $1.0M |
| Oct 29, 2025 | Basile Edward M 10b5-1 | Exercise M | 4.1K | — |
| Oct 29, 2025 | Basile Edward M 10b5-1 | Sell S | 4.1K | $540.3K |
| Oct 29, 2025 | Basile Edward M 10b5-1 | Exercise M | 4.1K | $2.9K |
| Aug 7, 2025 | Hassanein Waleed H KEY | Buy P | 16.9K3 lots | $2.0M |
| Aug 4, 2025 | Basile Edward M 10b5-1 | Exercise M | 4.1K | — |
| Aug 4, 2025 | Basile Edward M 10b5-1 | Sell S | 4.1K | $520.0K |
| Aug 4, 2025 | Basile Edward M 10b5-1 | Exercise M | 4.1K | $2.9K |
Buy Sell Non-market (grant · exercise · gift)
About TMDX insider trading
This page tracks insider transactions for TransMedics Group, Inc. (TMDX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.